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would make German industries 
less competitive. Others, however, 
most remarkably including former 
supporters of nuclear power on the 
conservative side of the political 
spectrum, have argued that this 
challenge is manageable, and that 
the requirement to make production 
more energy-efficient will also give 
German manufacturers an advantage 
internationally. 
A model for other countries?
Politicians and concerned citizens 
in other countries will observe 
Germany’s movements closely, 
as it is the first example of a high 
technology country turning its back 
on nuclear energy after using it for 
more than half a century. 
Around the world, many old and 
new users of nuclear reactors are 
sticking to their plans and policies, 
only adding a safety inspection here 
or there. At the EU level, the UK and 
France warned of any hasty decisions 
when Germany pressed for an  
EU-wide rethink. 
China, which has 13 nuclear 
reactors running and 28 being built, 
announced it would not change its 
plans, but ordered safety inspections 
and updates to the regulations in 
the light of the Fukushima accident. 
However, as nuclear security 
researcher Yun Zhou wrote in a 
report for the Harvard Kennedy 
School, awareness of nuclear risks 
is only beginning to emerge. “More 
and more people are just learning 
of China’s ambitious nuclear energy 
plan, which they did not pay much 
attention to before the Fukushima 
nuclear incident. Public concerns 
about nuclear safety could lead to 
questions about whether China can 
maintain sound nuclear safety culture 
and practices in light of China’s poor 
construction safety record,” Zhou 
concluded.
South Korea and India, each 
running around 20 nuclear plants and 
building additional ones, appear to 
be more worried, given their possible 
exposure to tsunamis. However, 
neither is seriously considering a 
change of policy. Similarly, Russia 
is sticking to its nuclear plants and 
hoping that other countries that have 
agreed to buy power stations from its 
company Rosatom will keep the faith 
in nuclear power as well. 
Some of the new members in the 
nuclear club, exposed as they are to natural and man-made disasters, 
would have good reasons to worry, 
though. An analysis carried out by 
Nature and Columbia University at 
New York revealed that more than 
200 nuclear power plants have more 
people living within a 30 km radius 
than Fukushima-Daiichi had. In 
Japan, 172,000 people living less 
than 30 km away from the stricken 
reactor had to be evacuated. The 
record holder is a plant in Karachi, 
Pakistan, where 8.2 million people 
would have to flee in similar 
circumstances. Two large nuclear 
plants in Taiwan are less than 30 km 
away from the capital Taipei, which 
means that each has around 5 million 
people living within this critical 
radius. 
So far, Switzerland is the closest 
to following the lead of its neighbour. 
The country currently produces 
more than half its electricity from 
hydroelectric generators, 40% 
from five nuclear plants, and small 
percentages from waste incineration, 
solar and wind power. In the wake of 
the Fukushima incident, the Swiss 
government has commissioned its 
environment ministry to explore a 
range of options, including phasing 
out nuclear power when the existing 
plants reach the end of their lifespan, 
and switching off nuclear plants 
even before their time runs out. The 
ministry’s report is due in June and 
will then be subject to parliamentary 
debate. 
As immediate measures, the Swiss 
government has frozen all three 
projects for new nuclear plants and 
ordered safety inspections for the 
existing ones. 
And what about Austria? In 1978, 
the country held a referendum 
deciding not to use nuclear power. 
Since then, it has become Europe’s 
leading producer of renewable 
energies, with 69% of its electricity 
produced from renewable sources, 
mostly hydroelectricity. If and when 
Germany and Switzerland switch off 
their reactors, Europe could end up 
with an enclave of German-speaking 
nuclear refuseniks on its map. 
Maybe it’s something to do with 
the German language. People in other 
countries just don’t have a word for 
‘Energiewende’.
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web 
page at www.michaelgross.co.ukLymphoid tissue 
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What are they? Lymphoid tissue 
inducer (LTi) cells are a hematopoietic 
cell type with critical roles in the 
immune system during both the 
embryonic and adult stages of 
development. Their distinguishing 
features are expression of RORgt 
and IL-7Ra in the absence of lineage 
markers (e.g. CD3, CD19, B220, 
CD11c, Gr-1). CD4 expression is 
something of a red herring (despite 
aiding identification), since both CD4+ 
and CD4– LTi cells exist in mice, whilst 
in humans they all appear to be CD4–. 
Constitutive expression of OX40L is 
another good marker for LTi cells in the 
adult (in mice and humans) (Figure 1).
Also known as... Although these cells 
were initially termed CD45+CD4+CD3– 
cells, on the basis of the expression 
of these surface markers, they 
were named LTi cells following the 
recognition of their key role in the 
development of lymph nodes and 
Peyer’s patches. Recently these cells 
have been included in the growing list 
of innate lymphoid cells (ILCs).
When did they first come to 
prominence? Although identified as 
one of the first cells to colonise the 
developing lymph node anlagen, the 
demonstration that these cells (and 
secondary lymphoid tissue) were 
dependent upon expression of the 
orphan transcription factor RORgt  
really brought LTi cells to the 
immunological foreground with RORg –/–  
mice providing an in vivo means of 
testing their function. The shared 
expression of RORgt by Th17  
cells also sparked interest in LTi  
cells.
When were they in their heyday? 
Now! Based on the almost monthly 
appearances of LTi cells in papers in 
top journals, it appears that a good 
proportion of the iceberg is within sight.
Not to be confused with... A host of 
recent papers have identified RORgt-
dependent cells that (to varying 
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Figure 1. A selection of molecules expressed by LTi cells in the embryo and adult that appear 
critical for the described functions of these cells. 
Molecules expressed by LTi cells in both the embryo and adult are shown in yellow and those 
expressed only in the adult are shown in orange. Lymphotoxin a1b2 (LTa1b2), RANKL, OX40L 
and CD30L are TNF superfamily members, and CXCR5, CCR7, CCR6 and CXCR6 are chemok-
ine receptors. IL-22, interleukin-22; IL-7Ra, interleukin-7 receptor a. degrees) are phenotypically distinct 
from LTi cells. These cells have only 
been identified within the adult, and 
LTi cells appear to be the only (non-
T-cell) RORgt-expressing population 
in the embryo. Notably, cells with a 
phenotype near identical to LTi cells, 
but also expressing natural killer cell 
markers, have been reported within 
the small intestine. Given that these 
cells have not been detected in the 
embryo, they do not appear to be 
involved in secondary lymphoid tissue 
formation. The lineage relationships 
between these populations is currently 
being debated. 
Bone of contention... Given their 
name, implicitly implied in their 
function is the ability to induce 
formation of secondary lymphoid 
tissue. Whilst LTi cells persist after 
birth, it is technically very difficult 
to demonstrate that these cells are 
still able to induce the formation of 
secondary lymphoid tissue, although it 
has been shown that they can induce 
Peyer’s patch formation in neonatal 
mice lacking these structures. 
Therefore, there is some concern that 
the continued use of the name LTi cell, 
when describing these cells in the 
adult, may be misleading. 
What was their earliest known 
function? LTi cells are clearly required 
for the formation of lymph nodes and 
Peyer’s patches — but interestingly not 
for the formation of organised splenic 
white pulp — through the provision 
of the tumour necrosis factor (TNF) superfamily ligands lymphotoxin a1b2 
and RANKL. These cells also induce 
the expression of the autoimmune 
regulator (AIRE) gene by medullary 
thymic epithelial cells in the developing 
embryonic thymus through provision 
of RANKL signals. Therefore, LTi cells 
in the embryo are the critical providers 
of both lymphotoxin a1b2 and RANKL 
signals, before lymphocyte populations 
have reached the periphery.
And their newly identified functions? 
Because the formation of secondary 
lymphoid tissue is restricted to 
a specific window of embryonic 
development, whether the LTi cells 
identified in the adult had acquired 
additional functions became of great 
interest. A number of studies using 
RORgt-deficient mice have implicated 
LTi cells in the recovery of splenic 
architecture after viral infection,  
T-cell-independent immunoglobulin 
A switching in the gut, and enhanced 
tumour rejection. Furthermore, much 
work has focused on the production 
of the interleukins IL-22 and IL-17 by 
LTi (and LTi-like) cells within the gut. 
The function of LTi cells in the embryo 
centres around their expression of the 
TNF superfamily members at a critical 
time and place. Interestingly, after birth 
LTi cells constitutively express high 
levels of two other TNF superfamily 
members — OX40L and CD30L — and 
become critical providers of these 
signals to memory CD4+ T cells. The 
formation of lymph nodes and the ability 
to generate memory immune responses 
co-evolved only within placental mammals. Therefore, LTi cells not only 
orchestrate the formation of lymph 
nodes, but they also enable the survival 
of memory CD4+ T cells within these 
structures. 
Most outrageous claim... A few years 
ago most of the current ideas about 
function would have been dismissed out 
of hand so perhaps we should wait a 
while longer before ruling anything out....
What are their known associates? 
Stromal cells in both lymphoid tissue 
development and perhaps resistance 
to tumours. Beyond that, interactions 
with nearly every hematopoietic cell 
imaginable have been suggested.
Obvious question we still don’t know 
the answer to... Given the similarities 
between the development of secondary 
lymphoid tissue and the formation of 
organised lymphoid aggregates during 
chronic inflammations, a role for LTi 
cells in the establishment of tertiary 
lymphoid tissue is suspected but as yet 
unproven.
Any therapeutic potential? The role 
of LTi cells (and OX40L/CD30L) in the 
survival of memory CD4+ T cells has 
significant implications for improving 
desired memory responses after 
vaccination as well as in the potential 
elimination of autoreactive cells. 
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